This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eloxx Pharmaceuticals Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Dori Pelled: Innovator in Rett Syndrome Treatment
Introduction
Dori Pelled is a notable inventor based in Hod-Hasharon, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Rett syndrome. His innovative work has the potential to impact the lives of many affected by this condition.
Latest Patents
Dori Pelled holds a patent for the use of aminoglycoside analogs in the treatment of Rett syndrome. The patent details compounds, methods, and uses of pseudo-trisaccharide aminoglycosides represented by a specific general formula. This invention aims to provide new therapeutic options for individuals suffering from Rett syndrome.
Career Highlights
Throughout his career, Dori Pelled has been associated with Eloxx Pharmaceuticals Ltd., where he has contributed to the development of groundbreaking treatments. His expertise in pharmaceutical sciences has positioned him as a key figure in the industry.
Collaborations
Dori Pelled has worked alongside talented colleagues such as Timor Baasov and Shmuel Tuvia. Their collaborative efforts have further advanced the research and development of innovative treatments in the pharmaceutical sector.
Conclusion
Dori Pelled's work exemplifies the spirit of innovation in the medical field. His contributions to the treatment of Rett syndrome highlight the importance of research and development in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile